Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $7.0 million.

  • Arcus Biosciences' Non Operating Income fell 4615.38% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year decrease of 2857.14%. This contributed to the annual value of $48.0 million for FY2024, which is 2307.69% up from last year.
  • Arcus Biosciences' Non Operating Income amounted to $7.0 million in Q3 2025, which was down 4615.38% from $8.0 million recorded in Q2 2025.
  • Arcus Biosciences' Non Operating Income's 5-year high stood at $13.0 million during Q2 2024, with a 5-year trough of $154000.0 in Q1 2021.
  • In the last 5 years, Arcus Biosciences' Non Operating Income had a median value of $8.0 million in 2023 and averaged $6.7 million.
  • As far as peak fluctuations go, Arcus Biosciences' Non Operating Income crashed by 7619.78% in 2021, and later soared by 408848.17% in 2023.
  • Quarter analysis of 5 years shows Arcus Biosciences' Non Operating Income stood at $519000.0 in 2021, then surged by 1248.75% to $7.0 million in 2022, then soared by 57.14% to $11.0 million in 2023, then dropped by 9.09% to $10.0 million in 2024, then dropped by 30.0% to $7.0 million in 2025.
  • Its last three reported values are $7.0 million in Q3 2025, $8.0 million for Q2 2025, and $10.0 million during Q1 2025.